Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab Combined With Definitive Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients

NCT06256224 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06256224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06256224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab Combined With Definitive Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 2, 2024
Completion date
December 31, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, chemoradiotherapy, immunotherapy